1. Home
  2. NEO vs BSTZ Comparison

NEO vs BSTZ Comparison

Compare NEO & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

N/A

Current Price

$15.00

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

BSTZ

BlackRock Science and Technology Term Trust of Beneficial Interest

N/A

Current Price

$24.04

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NEO
BSTZ
Founded
2001
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NEO
BSTZ
Price
$15.00
$24.04
Analyst Decision
Buy
Analyst Count
11
0
Target Price
★ $23.40
N/A
AVG Volume (30 Days)
★ 1.6M
197.4K
Earning Date
10-28-2026
01-01-0001
Dividend Yield
N/A
★ 8.31%
EPS Growth
N/A
N/A
EPS
N/A
★ 0.71
Revenue
N/A
N/A
Revenue This Year
$11.12
N/A
Revenue Next Year
$9.68
N/A
P/E Ratio
★ N/A
$33.69
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$20.69
52 Week High
$20.15
$31.89

Technical Indicators

Market Signals
Indicator
NEO
BSTZ
Relative Strength Index (RSI) 35.28 35.17
Support Level $13.43 $22.95
Resistance Level $15.31 $31.59
Average True Range (ATR) 0.80 0.95
MACD -0.20 -0.09
Stochastic Oscillator 3.34 16.97

Price Performance

Historical Comparison
NEO
BSTZ

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest

BlackRock Science and Technology Trust II is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income mainly through long-term capital appreciation. The Trust invests a majority of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement, and use of science and/or technology. Its investment portfolio comprises securities of companies from various industries, such as semiconductors and semiconductor equipment, software, communications equipment, IT services, and entertainment, etc.

Share on Social Networks: